GoodRx Holdings Inc.

NASDAQ: GDRX
$4.99
+$0.18 (+3.7%)
Closing price January 26, 2023
Tuesday afternoon's top analyst upgrades and downgrades included Charter Communications, Comcast, Farfetch, GoodRx, Lincoln National and Vroom.
Tuesday afternoon's top analyst upgrades and downgrades included Boot Barn, Cigna, Comerica, GoodRx, Oracle and United Rentals.
Friday’s top analyst upgrades and downgrades included Alphabet, Doximity, IBM, Marriott International, Marvell Technology, Snap, Teladoc Health, TripAdvisor, Twitter, Uber Technologies and Zillow.
Tuesday’s top analyst upgrades and downgrades included Dominion Energy, FireEye, GoodRx, Intuit, Occidental Petroleum, Unity Software and Virgin Galactic.
Monday's top analyst upgrades and downgrades included Darden Restaurants, Foot Locker, Gap, Kellogg, Moderna, Philip Morris International, Prologis, Rockwell Automation and Texas Roadhouse.
Thursday's top analyst upgrades and downgrades included Boeing, Citigroup, Cree, FuelCell Energy, Lowe's Companies, NextEra Energy, Nio, Nvidia, Shopify, Sonos, Square, Target, Uber and Yelp.
Wednesday's top analyst upgrades and downgrades included Baidu, BigCommerce, Boeing, Ciena, Deere, GoodRx, Kohl's, ONEOK, Tesla and Walmart.
The post-IPO quiet period for GoodRx is over, and now analysts are rushing to make calls on the stock. For the most part, sentiment seems relatively positive.